Nortem Biogroup (XPAR:MLBIO) Interest Coverage : 9.32 (As of Dec. 2022)

View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Nortem Biogroup's Operating Income for the six months ended in Dec. 2022 was €0.63 Mil. Nortem Biogroup's Interest Expense for the six months ended in Dec. 2022 was €-0.07 Mil. Nortem Biogroup's interest coverage for the quarter that ended in Dec. 2022 was 9.32. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Nortem Biogroup's Interest Coverage or its related term are showing as below:

XPAR:MLBIO' s Interest Coverage Range Over the Past 10 Years
Min: 7.33 Med: 8.33 Max: 9.32
Current: 9.32

XPAR:MLBIO's Interest Coverage is not ranked
in the Consumer Packaged Goods industry.
Industry Median: 8.59 vs XPAR:MLBIO: 9.32

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Nortem Biogroup Interest Coverage Historical Data

The historical data trend for Nortem Biogroup's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Nortem Biogroup Interest Coverage Chart

Nortem Biogroup Annual Data

Trend

Dec21

Dec22

Interest Coverage

7.33

9.32

Nortem Biogroup Semi-Annual Data
	Dec21	Dec22
Interest Coverage	7.33	9.32

Competitive Comparison of Nortem Biogroup's Interest Coverage

For the Packaged Foods subindustry, Nortem Biogroup's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nortem Biogroup's Interest Coverage Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Nortem Biogroup's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Nortem Biogroup's Interest Coverage falls into.

Nortem Biogroup Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage

-1

Operating Income

Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt ⁽¹⁾.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Nortem Biogroup's Interest Coverage for the fiscal year that ended in Dec. 2022 is calculated as

Here, for the fiscal year that ended in Dec. 2022, Nortem Biogroup's Interest Expense was €-0.07 Mil. Its Operating Income was €0.63 Mil. And its Long-Term Debt & Capital Lease Obligation was €3.39 Mil.

Interest Coverage	=	-1	*	Operating Income (A: Dec. 2022 )	/	Interest Expense (A: Dec. 2022 )
	=	-1	*	0.634	/	-0.068
	=	9.32

Nortem Biogroup's Interest Coverage for the quarter that ended in Dec. 2022 is calculated as

Here, for the six months ended in Dec. 2022, Nortem Biogroup's Interest Expense was €-0.07 Mil. Its Operating Income was €0.63 Mil. And its Long-Term Debt & Capital Lease Obligation was €3.39 Mil.

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2022 )	/	Interest Expense (Q: Dec. 2022 )
	=	-1	*	0.634	/	-0.068
	=	9.32

The higher the ratio, the stronger the company's Financial Strength is.

Nortem Biogroup (XPAR:MLBIO) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Nortem Biogroup Interest Coverage Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.

Nortem Biogroup (XPAR:MLBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Interest Coverage

Comparable Companies

Traded in Other Exchanges

N/A

Address

Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500

Website

https://www.nortembiogroup.com

Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup (XPAR:MLBIO) Headlines

No Headlines